These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4967772)

  • 21. [Isolation and properties of highly purified C1. botulinum toxin type E].
    Levdikova GA; Klimacheva LV; Ispolatovskaia MV; Bulatova TI; Anisimova LI
    Biokhimiia; 1979 Aug; 44(8):1392-400. PubMed ID: 115504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cation-exchange chromatography of Clostridium botulinum type A toxin on amberlite IRC-50 resin at pH 5.55.
    Dasgupta BR; Boroff DA; Cheong K
    Biochim Biophys Acta; 1968 Dec; 168(3):522-31. PubMed ID: 4973552
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultracentrifugal analysis of the crystalline toxin and isolated fractions of Clostridium botulinum type A.
    Boroff DA; Townend R; Fleck U; DasGupta BR
    J Biol Chem; 1966 Nov; 241(22):5165-7. PubMed ID: 4959143
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence that botulinum C2 toxin has two dissimilar components.
    Iwasaki M; Ohishi I; Sakaguchi G
    Infect Immun; 1980 Aug; 29(2):390-4. PubMed ID: 7011974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and some properties of Clostridium botulinum type-E toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochim Biophys Acta; 1968 Oct; 168(2):207-17. PubMed ID: 4972262
    [No Abstract]   [Full Text] [Related]  

  • 26. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromatographic purification of the toxin of type E Clostridium botulinum.
    Emodi AS; Lechowich RV
    Biochem Biophys Res Commun; 1969 Jun; 35(6):788-95. PubMed ID: 4893076
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation phenomenon of Clostridium botulinum type E toxin.
    GERWING J; DOLMAN CE; ARNOTT DA
    J Bacteriol; 1962 Aug; 84(2):302-6. PubMed ID: 13898102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Snake venom toxins. Purification and properties of three toxins from Naja nivea (Linnaeus) (Cape cobra) venom and the amino acid sequence of toxin delta.
    Botes DP; Strydom DJ; Anderson CG; Christensen PA
    J Biol Chem; 1971 May; 246(10):3132-9. PubMed ID: 4995745
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH; Lecroisey A; Alouf JE
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of botulin toxins and anatoxins by the gel filtration method. II. Separation of native type A botulin toxins by filtration through Sephadex G-200 gel].
    Freĭman VB; Golshmid VK; Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):106-9. PubMed ID: 4891690
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of a protein, insoluble at low temperature, produced by Clostridium botulinum type G.
    Giménez JA; Cascone O; Biscoglio de Jimenez Bonino MJ; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):179-88. PubMed ID: 3538716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the toxin of Clostridium botulinum. Effects of 2-hydroxy-5-nitrobenzyl bromide on the biological activity of botulinum toxin.
    Boroff DA; Dasgupta BR
    Biochim Biophys Acta; 1966 Apr; 117(2):289-96. PubMed ID: 5335812
    [No Abstract]   [Full Text] [Related]  

  • 38. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium botulinum type C toxin: a sketch of the molecule.
    Syuto B; Kubo S
    Mol Cell Biochem; 1982 Oct; 48(1):25-32. PubMed ID: 6817077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.